IT1051559B
(it)
*
|
1972-02-29 |
1981-05-20 |
Acraf |
Procedimento per la peparazione di derivati della s.triazolo 4.3.a piridina
|
JPS5070389A
(it)
*
|
1973-10-30 |
1975-06-11 |
|
|
US4154832A
(en)
*
|
1974-08-26 |
1979-05-15 |
Bruno Silvestrini |
Novel treatment for acute organic cerebral syndromes (strokes)
|
IT1073639B
(it)
*
|
1976-05-05 |
1985-04-17 |
Acraf |
Impiego del trazodone e etoperidone nel morbo di parikinson ed in altre sindromi extrapiramidali caratterizzate da tremori
|
US4162318A
(en)
*
|
1976-05-05 |
1979-07-24 |
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. |
Use of trazodone and etoperidone in Parkinsonism and in other extrapyramidal syndromes characterized by tremors
|
IT1094076B
(it)
*
|
1978-04-18 |
1985-07-26 |
Acraf |
Cicloalchiltriazoli
|
US4465683A
(en)
*
|
1979-09-14 |
1984-08-14 |
Mead Johnson & Company |
Anti-psychotic agents
|
US4252806A
(en)
*
|
1979-09-24 |
1981-02-24 |
Mead Johnson & Company |
Triazoloquinolones
|
US4254124A
(en)
*
|
1979-09-24 |
1981-03-03 |
Mead Johnson & Company |
Antidepressant agent
|
US4251530A
(en)
*
|
1980-02-19 |
1981-02-17 |
Merck & Co., Inc. |
2-{[4-(6-Substituted-2-pyrazinyl)-1-piperazinyl]alkyl}-5-substituted-1,2,4-triazolo[4,3-a]pyridin-3(2H)-one analgesic agents
|
IT1147349B
(it)
*
|
1980-04-09 |
1986-11-19 |
Acraf |
2-parentesi quadra aperta 3-parentesi quadra aperta 4-(3-cloro-4-fluorofenil)-1-piperfrazinil parentesi quadra propil parentesi quadra chiusa-1,2,4-triazolo parentesi quadra aperta 4,3 parentesi quadra chiusa piridin-3(2h)-one
|
US4338317A
(en)
*
|
1981-03-16 |
1982-07-06 |
Mead Johnson & Company |
Phenoxyethyl-1,2,4,-triazol-3-one antidepressants
|
US4487773A
(en)
*
|
1981-03-16 |
1984-12-11 |
Mead Johnson & Company |
1,2,4-Triazol-3-one antidepressants
|
US4340597A
(en)
*
|
1981-04-13 |
1982-07-20 |
Schering Corporation |
1-Substituted-4-aryl-1,2,5,6-tetrahydro and hexahydropyridines
|
US4386091A
(en)
*
|
1982-02-24 |
1983-05-31 |
Mead Johnson & Company |
2-Phenoxyalkyl-1,2,4-triazol-3-one antidepressants
|
US4575555A
(en)
*
|
1983-06-29 |
1986-03-11 |
Mead Johnson & Company |
4-(3-Chlorophenyl)-1,2,3,6-tetrahydropyridine derivative
|
US4613600A
(en)
*
|
1983-09-30 |
1986-09-23 |
Mead Johnson & Company |
Antidepressant 1,2,4-triazolone compounds
|
US4596807A
(en)
*
|
1985-03-26 |
1986-06-24 |
Serotonin Industries Of Charleston |
Method and compositions for controlling pain, depression and sedation
|
FR2580648B1
(fr)
*
|
1985-04-17 |
1987-05-15 |
Adir |
Nouveaux derives du triazole, leur procede de preparation et les compositions pharmaceutiques les renfermant
|
US4840952A
(en)
*
|
1985-11-01 |
1989-06-20 |
Bristol-Myers Company |
Method for treatment of male impotence
|
US4687771A
(en)
*
|
1985-11-01 |
1987-08-18 |
Bristol-Myers Company |
Method for treatment of male impotence
|
US4784998A
(en)
*
|
1987-04-06 |
1988-11-15 |
Bristol-Myers Company |
1,3,4-oxadiazole pyschotropic compounds
|
GEP20001939B
(en)
*
|
1992-01-17 |
2000-02-05 |
Angelini Ricerca S P A Soc Consortile |
Alkyl Derivatives of Trazodone with CNS Activity
|
US5543563A
(en)
*
|
1992-01-17 |
1996-08-06 |
Istituto Ricerca Francesco Angelini S.P.A. |
Alkyl derivatives of trazodone with CNS activity
|
IT1268414B1
(it)
*
|
1993-07-01 |
1997-02-27 |
Angelini Francesco Ist Ricerca |
Enantiomeri farmacologicamente attivi
|
CA2144669A1
(en)
*
|
1994-03-29 |
1995-09-30 |
Kozo Akasaka |
Biphenyl derivatives
|
CA2160423A1
(en)
*
|
1994-11-02 |
1996-05-03 |
Hemant N. Joshi |
Salts of nefazodone having improved dissolution rates
|
JPH11500123A
(ja)
*
|
1995-02-15 |
1999-01-06 |
ファルマシア・アンド・アップジョン・カンパニー |
CNSおよび心臓病の治療のためのイミダゾ[1,2−a]ピリジン類
|
DE19734516A1
(de)
*
|
1997-08-08 |
1999-02-11 |
Bayer Ag |
Verfahren zur Herstellung von N-Aryl-N'-alkyl-piperazinen
|
US6013654A
(en)
*
|
1997-08-14 |
2000-01-11 |
Pharmacia & Upjohn Company |
Imidazo[1,2-A]pyridines for the treatment of CNS and cardiac diseases
|
IL141235A
(en)
*
|
2000-02-09 |
2012-04-30 |
Novartis Int Pharm Ltd |
Combined use of an alpha-adrenoceptor antagonist and a muscarinic antagonist in the preparation of a drug for the treatment of non-malignant prostatic hyperplasia
|
US20020065286A1
(en)
*
|
2000-08-21 |
2002-05-30 |
Davies Michael John |
Treatment of wounds
|
US20020091129A1
(en)
*
|
2000-11-20 |
2002-07-11 |
Mitradev Boolell |
Treatment of premature ejaculation
|
GB0130219D0
(en)
*
|
2001-12-18 |
2002-02-06 |
Pfizer Ltd |
Compounds for the treatment of sexual dysfunction
|
US20030229001A1
(en)
*
|
2002-01-31 |
2003-12-11 |
Pfizer Inc. |
Treatment of male sexual dysfunction
|
GB0219961D0
(en)
|
2002-08-28 |
2002-10-02 |
Pfizer Ltd |
Oxytocin inhibitors
|
TWI319713B
(en)
*
|
2002-10-25 |
2010-01-21 |
|
Sustained-release tramadol formulations with 24-hour efficacy
|
US8487002B2
(en)
*
|
2002-10-25 |
2013-07-16 |
Paladin Labs Inc. |
Controlled-release compositions
|
US7323462B2
(en)
*
|
2002-12-10 |
2008-01-29 |
Pfizer Inc. |
Morpholine dopamine agonists
|
CA2451267A1
(en)
*
|
2002-12-13 |
2004-06-13 |
Warner-Lambert Company Llc |
Pharmaceutical uses for alpha2delta ligands
|
PA8597401A1
(es)
*
|
2003-03-14 |
2005-05-24 |
Pfizer |
Derivados del acido 3-(1-[3-(1,3-benzotiazol-6-il) propilcarbamoil] cicloalquil) propanoico como inhibidores de nep
|
US20040220186A1
(en)
*
|
2003-04-30 |
2004-11-04 |
Pfizer Inc. |
PDE9 inhibitors for treating type 2 diabetes,metabolic syndrome, and cardiovascular disease
|
US20050065158A1
(en)
*
|
2003-07-16 |
2005-03-24 |
Pfizer Inc. |
Treatment of sexual dysfunction
|
US7291640B2
(en)
*
|
2003-09-22 |
2007-11-06 |
Pfizer Inc. |
Substituted triazole derivatives as oxytocin antagonists
|
US20060172006A1
(en)
*
|
2003-10-10 |
2006-08-03 |
Vincent Lenaerts |
Sustained-release tramadol formulations with 24-hour clinical efficacy
|
US20050267096A1
(en)
*
|
2004-05-26 |
2005-12-01 |
Pfizer Inc |
New indazole and indolone derivatives and their use pharmaceuticals
|
US20050288270A1
(en)
*
|
2004-05-27 |
2005-12-29 |
Pfizer Inc |
New aminopyridine derivatives and their use as pharmaceuticals
|
JP2008533193A
(ja)
*
|
2005-03-21 |
2008-08-21 |
ファイザー・リミテッド |
オキシトシン拮抗薬としての置換トリアゾール誘導体
|
JP2008533192A
(ja)
*
|
2005-03-21 |
2008-08-21 |
ファイザー・リミテッド |
オキシトシンアンタゴニストとしての置換されたトリアゾール誘導体
|
EP1917257A1
(en)
*
|
2005-08-10 |
2008-05-07 |
Pfizer Limited |
Substituted triazole derivatives as oxytocin antagonists
|
DK1931346T3
(da)
*
|
2005-09-09 |
2012-10-22 |
Angelini Labopharm Llc |
Trazodonsammensætning til indgivelse en gang om dagen
|
ITMI20071603A1
(it)
*
|
2007-08-03 |
2009-02-04 |
Acraf |
Trazodone e trazodone cloridrato in forma purificata
|
US8461389B2
(en)
|
2008-04-18 |
2013-06-11 |
University College Dublin, National University Of Ireland, Dublin |
Psycho-pharmaceuticals
|
TWI368512B
(en)
*
|
2009-04-30 |
2012-07-21 |
Univ Kaohsiung Medical |
Pharmaceutical compositions comprising chlorophenyl piperazine derived compounds and use of the compounds in producing medicaments
|
WO2012072665A1
(en)
|
2010-11-30 |
2012-06-07 |
Pharmaneuroboost N.V. |
Compositions comprising pipamperone and serotonin antagonist reuptake inhibitors
|
EP2785183B1
(en)
*
|
2011-11-14 |
2018-12-19 |
Merck Sharp & Dohme Corp. |
Triazolopyridinone pde10 inhibitors
|
CA2937417C
(en)
*
|
2014-01-21 |
2022-04-12 |
Piramal Enterprises Limited |
An improved process for the preparation of trazodone and hydrochloride salt thereof
|
WO2016192657A1
(en)
|
2015-06-03 |
2016-12-08 |
Sunshine Lake Pharma Co., Ltd. |
Substituted piperazine compounds and methods of use and use thereof
|
PL234822B1
(pl)
|
2017-03-14 |
2020-04-30 |
Politechnika Krakowska Im Tadeusza Kosciuszki |
Sposób otrzymywania trazodonu
|
RS63323B1
(sr)
|
2018-02-07 |
2022-07-29 |
Acraf |
Kontinualni postupak za dobijanje trazodona
|
RU2706700C1
(ru)
|
2019-09-24 |
2019-11-20 |
Общество с ограниченной ответственностью "Научно-производственная компания "СКиФФ" |
Фармацевтическая композиция для коррекции поведения кошек и собак в стрессовых ситуациях
|